Poniard Pharmaceuticals, Inc. Stock OTC Markets

Stocks

PARDP

US7324492021

Pharmaceuticals

OTC Markets Traded
Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for Poniard Pharmaceuticals, Inc. -.--% -

Valuation: Poniard Pharmaceuticals, Inc.

Market Cap 3.19M 2.79M 2.58M 2.37M 4.49M 307M 4.56M 30.75M 12.06M 150M 11.99M 11.73M 518M P/E 2009
-1.4x
P/E 2010 -0.79x
Enterprise Value 437K 382K 353K 324K 614K 42.08M 625K 4.21M 1.65M 20.57M 1.64M 1.61M 70.9M EV / Sales 2009
-
EV / Sales 2010 -
Free-Float
2.5%
Yield 2009 *
-
Yield 2010 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 149
+1.27%+0.24%+21.26%-7.92% 66.75B
+1.38%-5.23%+38.08%+194.04% 50.65B
+1.10%+38.30%+38.30%+38.30% 42.55B
-0.98%-1.79%-49.61%-53.35% 41.15B
+2.76%-1.56%+54.70%-29.15% 28.34B
+1.25%-7.48%+116.21%-44.31% 26.76B
+0.18%-1.85%+68.63%+88.43% 22.95B
+7.77%+11.30%+18.35%+199.08% 20B
-1.70%+5.53%+76.00%+157.99% 16.48B
Average +1.23%-2.38%+42.44%+60.34% 35.07B
Weighted average by Cap. +1.22%-2.97%+34.19%+48.59%

Financials

2009 2010
Net sales - -
Net income -45.72M -39.97M -36.87M -33.89M -64.22M -4.4B -65.32M -440M -173M -2.15B -172M -168M -7.41B -30.05M -26.27M -24.24M -22.28M -42.22M -2.89B -42.94M -289M -114M -1.41B -113M -110M -4.87B
Net Debt -23.12M -20.21M -18.65M -17.14M -32.48M -2.22B -33.03M -223M -87.34M -1.09B -86.82M -84.92M -3.75B -2.76M -2.41M -2.22M -2.04M -3.87M -265M -3.94M -26.54M -10.41M -130M -10.35M -10.12M -447M
Logo Poniard Pharmaceuticals, Inc.
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.
Employees
-